title: Enhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant mice.
abstract: Previous reports have indicated that adenosine A3 receptor (A3R) knockout mice are more sensitive to ischemic or hypoxic brain injury. The purpose of this study was to examine if suppression of A3R expression is associated with increase in sensitivity to injury induced by a high dose of methamphetamine (Meth). Adult male A3R null mutant (-/-) mice and their controls (+/+) were injected with four doses (2 h apart) of Meth (10 mg/kg) or saline. Animals were placed in a behavioral activity chamber, equipped with food and water, for 52 h starting from one day after injections. The first 4 h were used for studying exploratory behaviors, and the next 48 h were used to measure locomotor activity. High doses of Meth equally reduced the 4-h exploratory behavior in -/- and +/+ mice. Meth suppressed locomotor activity between 4 and 52 h in both groups, with a greater reduction being found in the -/- mice. Brain tissues were collected at 3 days after the Meth or saline injections. Meth treatment reduced striatal dopamine (DA) levels in both +/+ and -/- mice with an increase in 3,4-dihydroxyphenylacetic acid (DOPAC)/DA ratio being found only in -/- animals. Meth also significantly increased ionized calcium-binding adaptor molecule 1 (Iba-1) and cleaved caspase-3 level in striatum, as well as Iba-1 and TNFα mRNA expression in nigra in -/-, compared to +/+, mice. Previous studies have shown that pharmacological suppression of vesicular monoamine transport 2 (VMAT2) by reserpine enhanced Meth toxicity by increasing cytosolic DA and inflammation. A significant reduction in striatal VMAT2 expression was found in -/- mice compared to +/+ mice, suggesting that increase in sensitivity to Meth injury in -/- mice may be related to a reduction in VMAT2 expression in these mice. In conclusion, our data suggest that A3R -/- mice are more sensitive to high doses of Meth.
authors.affiliation: National Institute on Drug Abuse, Intramural Research Program, NIH, 251 Bayview Blvd, Baltimore, MD, 21224, USA.
authors.forename: H
authors.initials: H
authors.lastname: Shen
authors.forename: Y
authors.initials: Y
authors.lastname: Luo
authors.forename: S-J
authors.initials: SJ
authors.lastname: Yu
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000633:toxicity; D000818:Animals; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics; D005106:Exploratory Behavior / Q000187:drug effects; D008297:Male; D008694:Methamphetamine / Q000633:toxicity*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009154:Mutation; D009410:Nerve Degeneration / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D043684:Receptor, Adenosine A3 / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D043684:Receptor, Adenosine A3; D008694:Methamphetamine